RPE65 — MultiTargetDB

Summary

KEGG Pathways (2)

Associated Diseases (2)

Top Co-occurrence Targets

InChIKey	pChEMBL	Type	Targets	Clinical
`AELGQMBQOODIOM`	7.3	IC50	2	—
`CFOSOLIKFJEEDX`	7.3	IC50	2	—
`DEIHHTSBJQNHFW`	7.3	IC50	2	—
`DRRHECNAHQDECM`	7.3	IC50	2	—
`DSOSLQJPOPFVCY`	7.3	IC50	2	—
`FGQXXYKKJCMFRY`	7.3	IC50	2	—
`FQUTXAGYBOXJPP`	7.3	IC50	2	—
`GMMCWBZACBPCHH`	7.3	IC50	2	—
`HQCPMHDPQAVFCC`	7.3	IC50	2	—
`HVIRUGYMHXBIRP`	7.3	IC50	2	—
`HVIRUGYMHXBIRP`	7.3	IC50	2	—
`HWUFDIOCKNJOOK`	7.3	IC50	2	—
`ILECNJVUPCHOFQ`	7.3	IC50	2	—
`IPQJGLPIYPNWKY`	7.3	IC50	2	—
`ITJCAEKNZQOESR`	7.3	IC50	2	—
`IZKQLYLRKORKAO`	7.3	IC50	2	—
`KQZPWHFGQRFKQO`	7.3	IC50	2	—
`LNBXGLYGRWKNFX`	7.3	IC50	2	—
`LOMJAUAGGZEKMG`	7.3	IC50	2	—
`LTLIQSUDCXOVAN`	7.3	IC50	2	—
`NJAPRLZUUBTINT`	7.3	IC50	2	—
`NLJSHOJXPLFAMP`	7.3	IC50	2	—
`NSGYLAFUEUWQGN`	7.3	IC50	2	—
`OAORXBINVBJVHC`	7.3	IC50	2	—
`PLYSOQQPLPMQQX`	7.3	IC50	2	—
`POHAQOMTRQSQBF`	7.3	IC50	2	—
`POQKMXYKZIXGBY`	7.3	IC50	2	—
`QHRFBQQOXXXMBG`	7.3	IC50	2	—
`QHRFBQQOXXXMBG`	7.3	IC50	2	—
`QUJJRUASXFHCKJ`	7.3	IC50	2	—
`QVFHDMUQYSVRAM`	7.3	IC50	2	—
`QVFHDMUQYSVRAM`	7.3	IC50	2	—
`RZOFTSAKOJCNAC`	7.3	IC50	2	—
`SCMCMUZZEREMHL`	7.3	IC50	2	—
`SNRBLZRKHAXORD`	7.3	IC50	2	—
`SOEYVCWIGWTSCS`	7.3	IC50	2	—
`SOEYVCWIGWTSCS`	7.3	IC50	2	—
`SOQGGCJSJULHNA`	7.3	IC50	2	—
`SVFWVHULYVAWDJ`	7.3	IC50	2	—
`UJKYMMTZGZLXSQ`	7.3	IC50	2	—
`UKGLBXMFKJXRKT`	7.3	IC50	2	—
`UZBSFEKGBAIRRT`	7.3	IC50	2	—
`UZBSFEKGBAIRRT`	7.3	IC50	2	—
`VIMZMXLDPBJYAH`	7.3	IC50	2	—
`VSYFAOVKTCHIQI`	7.3	IC50	2	—
`WISINULCFMQUAA`	7.3	IC50	2	—
`WJIGGYYSZBWCGC`	7.3	IC50	2	—
`WPCZEAMENQWERT`	7.3	IC50	2	—
`WUJWCUNZFGPNFF`	7.3	IC50	2	—
`XCBDVZLXPCZACU`	7.3	IC50	2	—